These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28579171)

  • 1. The NDR/LATS protein kinases in immunology and cancer biology.
    Sharif AAD; Hergovich A
    Semin Cancer Biol; 2018 Feb; 48():104-114. PubMed ID: 28579171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.
    Hergovich A; Hemmings BA
    Biofactors; 2009; 35(4):338-45. PubMed ID: 19484742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of NDR Protein Kinases in Hippo Signalling.
    Hergovich A
    Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Kinase Activities of the LATS/NDR Protein Kinases.
    Hergovich A
    Methods Mol Biol; 2019; 1893():305-317. PubMed ID: 30565143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression.
    Cornils H; Kohler RS; Hergovich A; Hemmings BA
    Cell Cycle; 2011 Jun; 10(12):1897-904. PubMed ID: 21593588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
    Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NDR/LATS protein kinases in neurobiology: Key regulators of cell proliferation, differentiation and migration in the ocular and central nervous system.
    Santos PF; Fazendeiro B; Luca FC; Ambrósio AF; Léger H
    Eur J Cell Biol; 2023 Jun; 102(2):151333. PubMed ID: 37327741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ndr/Lats Kinases Bind Specific Mob-Family Coactivators through a Conserved and Modular Interface.
    Parker BW; Gogl G; Bálint M; Hetényi C; Reményi A; Weiss EL
    Biochemistry; 2020 May; 59(17):1688-1700. PubMed ID: 32250593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.
    Hergovich A
    Cell Biosci; 2013 Aug; 3(1):32. PubMed ID: 23985307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential NDR/LATS interactions with the human MOB family reveal a negative role for human MOB2 in the regulation of human NDR kinases.
    Kohler RS; Schmitz D; Cornils H; Hemmings BA; Hergovich A
    Mol Cell Biol; 2010 Sep; 30(18):4507-20. PubMed ID: 20624913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
    Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS
    EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D
    FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development.
    Lee DH; Park JO; Kim TS; Kim SK; Kim TH; Kim MC; Park GS; Kim JH; Kuninaka S; Olson EN; Saya H; Kim SY; Lee H; Lim DS
    Nat Commun; 2016 Jun; 7():11961. PubMed ID: 27358050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases.
    Bao Y; Sumita K; Kudo T; Withanage K; Nakagawa K; Ikeda M; Ohno K; Wang Y; Hata Y
    Genes Cells; 2009 Dec; 14(12):1369-81. PubMed ID: 19919647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways.
    Duhart JC; Raftery LA
    Front Cell Dev Biol; 2020; 8():161. PubMed ID: 32266255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.